Naoto Hirano

15PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 21, 2026
CD28-driven ex vivo generation of stem-like memory CD8+ T cells bypassing CD3/TCR signaling.

|Sep 27, 2022
Modification of the HLA-A*24:02 Peptide Binding Pocket Enhances Cognate Peptide-Binding Capacity and Antigen-Specific T Cell Activation.

Kenji Murata, Dalam Ly, Hiroshi Saijo

|Jul 14, 2022
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy.

Giselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser

|May 27, 2022
Characterization of Proteasome-Generated Spliced Peptides Detected by Mass Spectrometry.

Koji Kato, Munehide Nakatsugawa, Serina Tokita

|Oct 29, 2021
Heterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.

Nisha Kanwar, Zaldy Balde, Ranju Nair

|Mar 02, 2021
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells.

Kenji Sugata, Yukiko Matsunaga, Yuki Yamashita

Pageof 3

Frequent Collaborators

8 joint publications

Marcus O Butler

4 joint publications

Tingxi Guo

3 joint publications

Kenji Murata

2 joint publications

Yuki Kagoya